Tumour-induced osteomalacia: a literature review and a case report (Q28069314)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

0 references

0 references

Tumour-induced osteomalacia: a literature review and a case report (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

3 April 2019

1 reference

3 April 2019

paraneoplastic syndrome

1 reference

3 April 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Jolanta Dadoniene

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marius Miglinas

2

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Dalia Miltiniene

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Dmitrij Seinin

5

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Petras Butenas

6

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Tomas Kacergius

7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

language of work or name

1 reference

8 January 2016

7 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

3 April 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

World Journal of Surgical Oncology

4 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

14

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

4

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

4 March 2020

copyright license

5 references

13 March 2019

14 March 2019

19 March 2019

24 March 2019

on focus list of Wikimedia project

3 April 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: Report of 39 cases and review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

How fibroblast growth factor 23 works

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Surgical treatment of tumor-induced osteomalacia: a retrospective review of 40 cases with extremity tumors

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Sinonasal phosphaturic mesenchymal tumor: Case report and systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Tumor-induced osteomalacia resulting from primary cutaneous phosphaturic mesenchymal tumor: a case and review of the medical literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

The phosphaturic mesenchymal tumor: why is definitive diagnosis and curative surgery often delayed?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Oncogenic osteomalacia due to FGF23-expressing colon adenocarcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

The expanding family of hypophosphatemic syndromes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

The importance of whole body imaging in tumor-induced osteomalacia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Tumor-induced osteomalacia with elevated fibroblast growth factor 23: a case of phosphaturic mesenchymal tumor mixed with connective tissue variants and review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Selective venous catheterization for the localization of phosphaturic mesenchymal tumors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Tumor-induced osteomalacia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Fibroblast growth factor 23 and its role in phosphate homeostasis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Tumor-induced osteomalacia: successful treatment by radio-guided tumor surgery

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

The roles of specific genes implicated as circulating factors involved in normal and disordered phosphate homeostasis: frizzled related protein-4, matrix extracellular phosphoglycoprotein, and fibroblast growth factor 23.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Oncogenic osteomalacia: diagnostic importance of fibroblast growth factor 23 and F-18 fluorodeoxyglucose PET/CT scan for the diagnosis and follow-up in one case

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Review and Update: Oncogenic Osteomalacia-Rickets

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Crosstransplantation of kidneys in normal and Hyp mice. Evidence that the Hyp mouse phenotype is unrelated to an intrinsic renal defect

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Oncogenous osteomalacia and malignancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Oncogenic hypophosphataemic osteomalacia: biomarker roles of fibroblast growth factor 23, 1,25-dihydroxyvitamin D3 and lymphatic vessel endothelial hyaluronan receptor 1.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Cinacalcet in the management of tumor-induced osteomalacia

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Oncogenic hypophosphataemic osteomalacia mimicking bone metastases on isotope bone scan

2 June 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Surgical Treatments of Tumor-Induced Osteomalacia Lesions in Long Bones: Seventeen Cases with More Than One Year of Follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Radiofrequency ablation of a tumor causing oncogenic osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Tumor-Induced Osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Phosphaturic mesenchymal tumors show positive staining for somatostatin receptor 2A (SSTR2A).

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Oncogenic osteomalacia: two case reports with surprisingly different outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Tumor-induced osteomalacia: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Octreotide therapy for tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Localisation of mesenchymal tumours by somatostatin receptor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Comparison of 18F-FDG and 68Ga DOTATATE PET/CT in localization of tumor causing oncogenic osteomalacia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Octreotide for tumor-induced osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Therapeutic effects of anti-FGF23 antibodies in hypophosphatemic rickets/osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2FS12957-015-0763-7

Tumor-Induced Osteomalacia: Increased Level of FGF-23 in a Patient with a Phosphaturic Mesenchymal Tumor at the Tibia Expressing Periostin

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Tumor-induced osteomalacia: a single center experience.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Osteomalacia with Looser's nodes (Milkman's syndrome) due to a raised resistance to vitamin D acquired about the age of 15 years.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

A case of oncogenic osteomalacia detected by 111In-pentetreotide total body scan.

27 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4705745

Recurrent malignant variant of phosphaturic mesenchymal tumor with oncogenic osteomalacia

27 November 2018

1 reference

12 December 2020

[Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia]

1 reference

12 December 2020

Malignant phosphaturic mesenchymal tumor, mixed connective tissue variant of the tongue

1 reference

12 December 2020

Four cases of acquired hypophosphataemic ('oncogenic') osteomalacia. Problems of diagnosis, treatment and long-term management

1 reference

12 December 2020

Oncogenic hypophosphatemic osteomalacia associated with a nasal hemangiopericytoma

1 reference

12 December 2020

Development of tumor-induced osteomalacia in a subcutaneous tumor, defined by venous blood sampling of fibroblast growth factor-23

1 reference

12 December 2020

Rickets following bone tumor

1 reference

12 December 2020

Determination of the elimination half-life of fibroblast growth factor-23

1 reference

12 December 2020

Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity

1 reference

12 December 2020

Tumor-induced hypophosphatemic rickets in an adolescent boy--clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue

1 reference

12 December 2020

Clinical problem-solving. Wasting away

1 reference

12 December 2020

Whole-body (99m)Tc-octreotide scintigraphy with SPECT/CT to detect occult tumor inducing paraneoplastic osteomalacia

1 reference

12 December 2020

Oncogenic osteomalacia: culprit tumour detection whole body magnetic resonance imaging

1 reference

12 December 2020

Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice

1 reference

12 December 2020

10.1186/S12957-015-0763-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

4 March 2020

1 reference

9 September 2019

https://scigraph.springernature.com/pub.10.1186/s12957-015-0763-7

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

PubMed publication ID

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26744291%20AND%20SRC:MED&resulttype=core&format=json